Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

Mar 4th 2020, Crypto Chartbook – Sitting on your hands

Sitting on your hands More important than making money is not losing it. If you lose fifty percent of your investment money, you need to make one hundred percent profits, just to break even. This counter intuitive principle works against you. If you trade a normally slow ...
Korbinian Koller | March 5, 2020 |

Precious Metals Reentry Time: Not Ideal but Enough for a Trade

I was looking over the charts last night (over a fine Merlot and some fava beans), trying desperately to avoid the temptation of attending that embarrassment of capitalism called PDAC. The mining conference held annually in Toronto has transformed from an industrial showc...
Streetwise Reports | March 11, 2019 |

No Respect

Rodney Dangerfield Wikimedia Commons In March 1967, for most of the adult population in North America, the most popular comedians were almost all television series personalities, such as Carol Burnett, Buddy Ebsen and Dick Van Dyke. ...
Streetwise Reports | May 5, 2020 |

The Company that’s taking Psychedelics from ‘Underground to Mainstream’

(Click image to play video) On a trip to Amsterdam, an item on many traveler’s agendas would be to indulge in some famed Dutch truffles. It is an experience to heighten the mind that Canadian public Company Red Light Holland Corp. (TRIP) ( CSE: T...
Dave Jackson | February 2, 2021 |

Bob Moriarty's Thoughts on the Coronavirus

If there was ever a time for real leaders to step forward and lead, the last four months would have been the time to do so. If there was an issue that demanded cooperation from all the nations of the world, we have seen it. Instead we have been fed a steady diet of disinf...
Streetwise Reports | April 20, 2020 |

Buzz on the Bullboards: Favourites in the Hot Sectors

(Image via Desert Mountain Energy Corp. Click to enlarge.) The fact that all companies are basically "fair game" on the Stockhouse Bullboards is one of its top highlights. In our review of the weekly top 6 most viewed companies by sector, newcomers might expect ...
Stockhouse Editorial | September 15, 2021 |

The Critical Investor Interviews Joe Grosso, CEO of Golden Arrow Resources

The Critical Investor sits down with Joe Grosso, CEO of Golden Arrow Resources, to discuss the company's exploration plans for the new year. 1. Introduction At a time when tax loss selling is at its peak, Golden Arrow Resources Corp. (GRG:TSX.V; GARWF:OTCQB;...
Streetwise Reports | December 20, 2019 |

Living in a virus-controlled world

As the coronavirus pandemic continues to infect populations, though in some countries it is slowing, talk has shifted to re-opening economies, and to manufacturing a vaccine that drug companies hope will not only work, but can be distributed at large enough doses to provide ...
Richard (Rick) Mills | April 24, 2020 |

Immunomedics Shares Double as Phase 3 Breast Cancer Trial Achieves 'Compelling' Efficacy Data

Shares of Immunomedics opened 117% higher after the company reported that it has stopped its Phase 3 ASCENT study of sacituzumab govitecan after recording "compelling evidence of efficacy" in heavily pretreated patients with metastatic triple-negative breast cancer. ...
Streetwise Reports | April 7, 2020 |

M2 Velocity Collapses – Could A Bottom In Capital Velocity Be Setting Up?

M2 Velocity is the measurement of capital circulating within the economy. The faster capital circulates within the economy, the more that capital is being deployed within the economy to create output and opportunities for economic growth. When M2 Velocity contracts, capital ...
Chris Vermeulen | May 28, 2020 |
1 2 3 4 5 6 7 8 9 10 ...